SightfileU.S. market data from official filings

Companies › VERU

Veru Inc (VERU)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000863894 · EDGAR filings · Updated 2026-07-02

Veru Inc (VERU) has reported institutional ownership of 21.4%, with 56 institutional managers holding positions valued at $7.58M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
21.4%
Institutional managers
56
Reported 13F value
$7.58M
Data flags
4 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Veru Inc has 56 institutional holders and institutional ownership of 21.4%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-13 (recurring since 2023-11-15) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-02-28 (recurring since 2024-01-26) — source filing. The authoritative details are those stated in the filing itself.
Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2025-01-03 (recurring since 2025-01-03) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2024-02-15 (recurring since 2023-11-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

VYNE THERAPEUTICS INC (VYNE) · QUOIN PHARMACEUTICALS LTD (QNRX) · DOGWOOD THERAPEUTICS INC (DWTX) · MediciNova Inc (MNOV) · BIOHARVEST SCIENCES INC (BHST) · CINGULATE INC (CING)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.